Sphere Fluidics
https://www.spherefluidics.com
Sphere Fluidics is a life sciences company, based in Cambridgeshire, UK and New Jersey, USA. Sphere Fluidics offers a novel platform (Cyto-Mine®) that performs single cell analysis.
Cyto-Mine® reduces costs for biopharmaceutical discovery and development. It is being adapted to single cell engineering using synthetic biology or genome editing.
In the media
27th March 2020
Cell Sorting Market, Size, Share, Outlook and Growth Opportunities 2019-2026
Also, in June 2019, Sphere Fluidics has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be
27th March 2020
Cell Sorting Market, Size, Share, Outlook and Growth Opportunities 2019-2026
Also, in June 2019, Sphere Fluidics has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be
27th March 2020
Cell Sorting Market, Size, Share, Outlook and Growth Opportunities 2019-2026
Also, in June 2019, Sphere Fluidics has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be